Author: Michael Walter Cardiovascular Business News Antihypertensive medications can improve COVID-19 survival rates and reduce the likelihood of severe illness, according to a new meta-analysis published in Current Atherosclerosis Reports. The study’s authors explored data from 19 different studies, focusing on the impact of renin-angiotensin-aldosterone system (RAAS) inhibitors such as angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor […]
Read MoreI want to thank all of our readers a fun and happy labor day. Please be safe
Read MoreAuthor: Michael Walter Cardiovascular Business News Blood pressure variability (BPV) from one visit to the next is associated with cognitive decline and even dementia, according to a new study published in Hypertension. “The clinical relevance of BPV has not been considered until recently,” wrote lead author Laure Rouch, PhD, PharmD, Paris Descartes University in France, […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Researchers in Sweden believe they may have identified a primary reason so many COVID-19 patients suffer from thrombosis, sharing their findings in Thrombosis and Haemostasis. The team’s discovery revolves around mannose-binding lectin (MBL), a protein that is part of the body’s natural immune system. Exploring data from 65 patients who […]
Read MoreDG Alerts A research letter published online in the Annals of the American Thoracic Society concluded that asthma may be an overestimated risk factor for hospitalisation due to coronavirus disease 2019 (COVID-19). Richard Broadhurst, University of Colorado Anschutz Medical Campus, Aurora, Colorado, and colleagues compared the prevalence of asthma among patients hospitalised for COVID-19, as reported in […]
Read MoreDG Alerts Researchers have identified a mechanism they believe explains why so many critically ill patients with coronavirus disease 2019 (COVID-19) have an increased risk of thromboembolic complications despite pharmacological thromboprophylaxis. In a cohort of 65 patients with severe COVID-19 in intensive care, Oskar Eriksson, MD, University Hospital, and Uppsala University, Uppsala, Sweden, and colleagues […]
Read MoreAuthors: Victor G. B. Liem, M.D., M.Sc. et al Anesthesiology 9 2020, Vol.133, 510-522. Background: Intraoperative hypotension has been associated with postoperative morbidity and early mortality. Postoperative hypotension, however, has been less studied. This study examines postoperative hypotension, hypothesizing that both the degree of hypotension severity and longer durations would be associated with myocardial injury.Methods: This single-center observational […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Researchers from Kaiser Permanente have identified a “striking association” between a person’s BMI and their risk of death from COVID-19, sharing their findings in Annals of Internal Medicine. “Approximately 42.4% of the U.S. adult population is obese, and 9.2% is severely obese,” wrote lead author Sara Y. Tartof, PhD, MPH, […]
Read MoreAuthor: Kat Eschner Popular Science Neither young adults nor their health care providers are actively looking for signs of the disease. Chadwick Boseman, the film actor who brought cinematic life to fictional and historical characters like the Black Panther, Jackie Robinson, James Brown, and Thurgood Marshall, died last week at the age of 43. Boseman […]
Read MoreDG Alerts Results of a meta-analysis published in the Journal of the American Medical Association suggest that the use of systemic corticosteroids in critically ill patients with COVID-19 was associated with lower 28-day all-cause mortality compared to usual care or placebo. The study also found that the benefit was the same regardless of age, sex or how long […]
Read More